NEUROPATHIX, INC. Retained Earnings
NEUROPATHIX, INC. had Retained Earnings of -$18.19 million as of 2022-03-31, per its 10-Q filed 2022-05-23.
Discontinued › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2022-05-23
- 2022-03-31: Retained Earnings (Accumulated Deficit) -$18.19M.
- 2021-12-31: Retained Earnings (Accumulated Deficit) -$16.59M.
- 2021-09-30: Retained Earnings (Accumulated Deficit) -$15.83M.
- 2021-06-30: Retained Earnings (Accumulated Deficit) -$15.11M.
| Period end | Retained Earnings (Accumulated Deficit) | Retained Earnings (Accumulated Deficit) as first filed |
|---|---|---|
| 2022-03-31 | -$18.19M 10-Q · filed 2022-05-23 | |
| 2021-12-31 | -$16.59M 10-Q · filed 2022-05-23 | |
| 2021-09-30 | -$15.83M 10-Q · filed 2021-11-12 | |
| 2021-06-30 | -$15.11M 10-Q · filed 2021-08-06 | |
| 2021-03-31 | -$14.36M 10-Q · filed 2021-05-13 | |
| 2020-12-31 | -$13.03M 10-K · filed 2022-04-15 | |
| 2020-09-30 | -$11.47M 10-Q · filed 2020-11-12 | |
| 2020-06-30 | -$10.86M 10-Q · filed 2020-08-12 | |
| 2020-03-31 | -$8.80M 10-Q · filed 2020-05-14 | |
| 2019-12-31 | -$8.50M 10-K · filed 2021-03-30 | |
| 2019-09-30 | -$7.76M 10-Q · filed 2019-11-13 | |
| 2019-06-30 | -$6.68M 10-Q · filed 2019-08-13 | |
| 2019-03-31 | -$5.90M 10-Q · filed 2019-05-14 | |
| 2018-12-31 | -$5.05M 10-K · filed 2020-03-30 | |
| 2018-09-30 | -$3.88M 10-Q · filed 2018-11-14 | |
| 2018-06-30 | -$159.78K 10-Q · filed 2018-07-27 | |
| 2018-03-31 | -$105.96K 10-Q · filed 2018-07-24 | |
| 2017-12-31 | -$5.99M 10-K · filed 2019-04-09 | -$84.57K 10-K · filed 2018-07-24 |
| 2017-09-30 | -$69.74K 10-Q · filed 2017-11-14 | |
| 2017-06-30 | -$65.68K 10-Q · filed 2017-08-18 | |
| 2017-03-31 | -$61.53K 10-Q · filed 2017-05-22 | |
| 2016-12-31 | -$62.13K 10-K · filed 2018-07-24 | |
| 2016-09-30 | -$31.09K 10-Q · filed 2016-11-21 | |
| 2016-06-30 | -$24.68K 10-Q · filed 2016-08-29 | |
| 2015-12-31 | -$30.10K 10-K · filed 2017-03-30 |